Succeeder Proudly Showcases Full Range of Coagulation Analyzers

coagulation

Beijing Succeeder proudly showcases its complete lineup of coagulation analyzers, covering full-tier models from entry-level to flagship: SF-400, SF-8050, SF-8100, SF-8200, SF-8300 and SF-9200. The diversified product portfolio meets the testing needs of primary hospitals, outpatient centers, tertiary hospitals and independent clinical laboratories worldwide.

As the core mid-range model, the SF-8200 fully automated coagulation analyzer is equipped with dual robotic arms, 8 detection channels and 42 refrigerated reagent positions. It achieves a PT throughput of ≥260 tests per hour. Adopting professional mechanical detection technology, the instrument effectively eliminates HIL interference caused by hemolysis, icterus and lipemia, ensuring stable and accurate test results. Its high-precision D-Dimer detection supports reliable VTE exclusion diagnosis in clinical practice.

The upgraded SF-8300 supports automatic tube piercing for high-throughput laboratory scenarios. The flagship SF-9200 delivers a maximum PT throughput of ≥415 tests per hour and is compatible with laboratory automation systems. Compact and lightweight models including SF-8100 and SF-8050 suit small and grassroots laboratories, while the semi-automatic SF-400 satisfies basic routine coagulation testing demands.

Compared with traditional optical detection devices, Succeeder’s mechanical-method coagulation systems feature lower retest rates, stronger anti-interference performance, wider detection linear range and lower long-term operational costs, bringing higher cost performance for clinical laboratory applications.

About Succeeder
Succeeder is a professional manufacturer dedicated to the R&D, production and global promotion of in vitro diagnostic instruments and reagents. Committed to technological innovation and reliable product quality, the company provides stable, efficient and cost-effective IVD solutions for global medical institutions.